Arrowhead Publishers and Conferences Company Profile

01:41 EDT 24th June 2018 | BioPortfolio

News Articles [326 Associated News Articles listed on BioPortfolio]

Arrowhead Plans Return to Clinic With New Study of Hep B Drug

Arrowhead Pharmaceuticals is back in the clinic. On Thursday, Pasadena, CA-based Arrowhead—which houses its research and development operations in Madison, WI—said regulators cleared the c...

Karger Publishers expands in the Middle East

(Karger Publishers) Karger Publishers has opened a new Regional Office in Dubai to extend its network in the Middle East. With this local presence, institutions and editors will get direct access to K...

Arrowhead ends enrolment in AROAAT1001 trial

Arrowhead Pharmaceuticals has completed patient enrolment in the Phase l AROAAT1001 trial of ARO-AAT for Treatment of Alpha-1 Liver Disease....Read More... The post Arrowhead ends enrolment in AROAAT1...

Silence Therapeutics has £43mln cash in the bank after Arrowhead disposal

Silence spent £8.3mln on a 10% stake in Arrowhead back in 2016 and has now sold it off for a profit of roughly £13.4mln

Arrowhead’s hepatitis B programme highlights bright future for RNAi therapy

At the 2018 European Association for the Study of the Liver (EASL) International Liver Congress (ILC), Arrowhead Pharmaceuticals presented positive...Read More... The post Arrowhead’s hepatitis B pr...

Karger Publishers partners with BenchSci

(Karger Publishers) Karger Publishers, a globally active medical and scientific publishing company, partners with BenchSci, a life science machine learning startup, to help scientists find biological ...

Silence Therapeutics sells another slug of its holding in Arrowhead

In total, Silence Therapeutics has now sold 6,358,850 Arrowhead shares on the open market, realising proceeds of US$23.0mln (£17.2mln)

Arrowhead's liver disease drug gets FDA orphan designation

The FDA gave orphan drug status to Arrowhead Pharmaceuticals' ARO-AAT, which is being developed as a treatment for patients w -More- 

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Creon [Abbott Products, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useIni...

Pancreaze [Ortho-McNeil-Janssen Pharmaceutical, Inc.]

These highlights do not include all the information needed to use PANCREAZE™ safely and effectively. See full prescribing information for PANCREAZE™.  PANCREAZE™ (pancrelipase) delayed-release ...

Creon [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) capsule, delayed release for oral use I...

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

PubMed Articles [59 Associated PubMed Articles listed on BioPortfolio]

Characteristics of E-Mail Solicitations From Predatory Nursing Journals and Publishers.

Predatory publishers solicit manuscripts through e-mail invitations to potential authors, with the goal of enticing authors to submit a manuscript to the journal. This descriptive study examined the c...

All publishers are predatory - some are bigger than others.

Discrepancy Between Neurosurgery Morbidity and Mortality Conference Discussions and Hospital Quality Metric Standards.

Medical institutions use quality metrics to track complications seen in hospital admissions. Similarly, morbidity and mortality (M&M) conferences are held to peer review complications. The purpose of ...

A Descriptive Study of Decision-Making Conversations during Pediatric Intensive Care Unit Family Conferences.

Little is known about how decision-making conversations occur during pediatric intensive care unit (PICU) family conferences (FCs).

Implementation status of morbidity and mortality conferences in Swiss hospitals: a national cross-sectional survey study.

To determine the implementation status and current practice of morbidity and mortality conferences (M&MCs) in Switzerland.

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPEN : Organization, Practices Evaluation in Perinatal Network)

This cluster-randomised controlled trial will test the hypothesis that a multifaceted program with psychological intervention in morbidity mortality conferences (MMC) improve care quality ...

The Effect of Case Conferencing in Nursing Homes

This study evaluates the effect of using comprehensive geriatric assessment in combination with case conferences on the prevalence of neuropsychiatric symptoms (also known as behavioral an...

How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?

This exploratory study is researching how the spirituality of a group of British patients with type 2 diabetes (T2D), impacts their approach to the self-management of their condition. ...

Yoga for Persistent Pain Related to Oncology Surgery

This randomized controlled trial will evaluate a yoga intervention for individuals who experience persistent pain following oncology surgery. The integrated yoga program will involve postu...

Oxidative Stress In Semen And Male Infertility

The proposed research aims to study the effects of antioxidant therapy, commonly used in male infertility treatment, on semen analysis. Patients presenting with male infertility, who are f...

Companies [272 Associated Companies listed on BioPortfolio]

Arrowhead Publishers & Conferences

Arrowhead Publishers and Conferences

Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis...

Arrowhead Research Corporation

Arrowhead Research Corporation ( (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronic...

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes...

More Information about "Arrowhead Publishers and Conferences" on BioPortfolio

We have published hundreds of Arrowhead Publishers and Conferences news stories on BioPortfolio along with dozens of Arrowhead Publishers and Conferences Clinical Trials and PubMed Articles about Arrowhead Publishers and Conferences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arrowhead Publishers and Conferences Companies in our database. You can also find out about relevant Arrowhead Publishers and Conferences Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record